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Abstract
Cavernous angiomas of the brain belong to a group of 
occult vascular malformations of the central nervous 
system, i. e. to changes not evident on conventional 
angiographic examinations. Intraoperatively or at 
autopsy, they represent raspberry-like clusters of veins. 
Magnetic resonance (MR) imaging of the brain is the 
diagnostic method of choice, where cavernomas 
typically appear as zones of mixed-signal intensity due 
to the presence of hemosiderin in the surrounding 
brain parenchyma. Familial form of cavernous 
angiomatosis is an autosomal dominant disorder which 
occurs as a result of the mutations in one of the three 
different genes, and is most often present in the 
Hyspanic-American population. Familial form of the 
disease is characterized by the presence of two or more 
lesions in the brain tissue, in two or more members of 
the same family. In 2008, three patients in close blood 
relation were hospitalized within a short period of time 
at the Neurosurgery Clinic Niš for multiple cavernous 
angiomas of the brain, as confirmed by MR imaging 
and a histopathologic finding in one surgically treated 
family member. Three other family members were 
subsequently examined and familial cavernous 
angiomatosis was confirmed in two additional 
members who were asymptomatic. MR imaging was 
performed using T1- and T2-weighted SE sequences 
and T2-weighted GRE sequence. The number of lesions 
seen in T2 SE (60) and T2 GRE (406) sequences was 
analyzed, and a discrepancy in the number of found 
cavernomas was displayed. The number of cavernomas 
by brain regions, the number of cavernomas in 
asymptomatic and symptomatic patients as well as 
their distribution, were also analyzed.
The obtained data show superiority of the T2 GRE 
sequence over T2 SE sequence in terms of sensitivity. 
Type IV cavernoma is detected only on T2 GRE images, 
according to Zabramski. Type IV cavernoma is one of 
the features of familial cavernous angiomatosis.
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Sažetak
Kavernozni angiomi mozga pripadaju grupi okultnih 
vaskularnih malformacija središnjeg živčanog sustava, 
tj. promjenama koje se ne prikazuju na klasičnim 
angiografskim ispitivanjima. Intraoperativno ili na 
autopsiji predstavljaju vensko klupko slično malini. 
Dijagnostička metoda izbora je MR mozga na kojem se 
kavernomi prikazuju najčešće kao zone mješovitog 
signala uslijed prisustva hemosiderina u okolnom 
moždanom parenhimu. Familijarni oblik kavernozne 
angiomatoze je autosomno-dominantno nasljedni 
poremećaj, koji se javlja kao posljedica mutacija na 
jednom od tri različita gena i najčešće je prisutan u 
hispanoameričkoj populaciji. Karakteristika familijar-
nog oblika oboljenja je prisustvo dvije ili više lezija u 
moždanom tkivu, kod dvije ili više osoba iz iste obitelji. 
Tijekom 2008. na Klinici za neurokirurgiju Niš je u 
kratkom vremenskom razdoblju hospitalizirano troje 
pacijenata u bliskom srodstvu kod kojih je dokazano 
postojanje multiplih kavernoznih angioma mozga 
realizacijom MR mozga uz patohistološku potvrdu 
kavernoma kod jednog operiranog bolesnika iz obitelji. 
Naknadno su ispitane još tri osobe iz obitelji pri čemu 
je pozitivan nalaz familijarne kavernozne angiomatoze 
potvrđen kod još dva člana koji su bili asimptomatski. 
1 Neurosurgery Clinic, Clinical Center of Niš 
2 Radiology Center, Clinical Center of Niš 
3 Neurosurgery Clinic, Clinical Center of Serbia 
Correspondence:
Nebojša Stojanović, MD, PhD, e-mail: nesamed59@gmail.com, Neurosurgery Clinic, Clinical Center, Niš, Zorana Đinđića 48, 18 000 Niš, Serbia
Radisav Mitić, MD e-mail: radisavmitic@gmail.com, Neurosurgery Clinic, Clinical Center, Niš, Zorana Đinđića 48, 18 000 Niš, Serbia
FAMILIAL CAVERNOUS ANGIOMATOSIS
Acta Chir Croat 2016; 13: 43–51
FAMILIAL CAVERNOUS ANGIOMATOSIS: CASE REPORT OF A 
FAMILY WITH MULTIPLE INTRACRANIAL LESIONS
Familijarna kavernozna angiomatoza: prikaz obitelji s multiplim 
intrakranijalnim lezijama
Radisav Mitić1, Nebojša Stojanović1, Zoran Radovanović2, Lukas Rasulić3
44
 PRIKAZ SLUČAJA / CASE REPORT Acta Chirurgica Croatica
MR mozga je realiziran uz upotrebu T1 i T2 SE, kao i T2 
GRE sekvence. Analiziran je broj lezija viđenih u T2 SE 
(60) i T2 GRE (406) sekvencama te je prikazana 
diskrepancija u nađenom broju kavernoma. Analiziran 
je broj kavernoma po regijama mozga, broj kavernoma 
kod asimptomatskih i simptomatskih pacijenata, kao i 
njihova distribucija.
Dobiveni podaci prikazuju superiornost T2 GRE 
sekvence u senzitivnosti u odnosu na T2 SE sekvencu. 
Tip IV kavernoma po Zabramskom detektira se samo na 
T2 GRE snimkama. Postojanje tipa IV kavernoma je 
jedna od karakteristika familijarne kavernozne 
angiomatoze.
Ključne riječi 
familijarna kavernozna angiomatoza, kavernom, 
kavernozni angiom, gradient recalled echo
Introduction 
Cavernous angiomas belong to the group of intracranial 
vascular malformations caused by a disorder in the 
development of the vascular bed. Macroscopically, 
they represent a collection of blood vessels resembling 
a raspberry [1]. They are mostly localized in the brain 
tissue, but can also be found in the spinal cord, retina or 
as skin changes [2, 3]. Pathohistologically, these are 
vascular channels made of walls that are lined with 
single endothelium, without smooth muscle tissue or 
elastic fibers, with the absence of brain tissue between 
the pathological blood vessels of the tangle. The 
number and size of these pathological channels inside 
the cavernoma grow throughout life.
Since cavernous angiomas are most often localized in 
the brain tissue, they can lead to epileptic seizures, 
focal neurological deficits or a fatal cerebral 
hemorrhage. Hemosiderin is present even in the 
absence of apparent hemorrhage in the surrounding 
parenchyma [4]. A quarter of patients are asymptomatic 
[5].
Considering that cavernous angiomas are not 
characterized by significant inflow of blood or 
significant venous drainage, they belong to occult 
vascular malformations that are not visible during 
conventional angiographic procedures. Owing to 
advances in MR imaging technology, cavernous 
angiomas are becoming one of the most commonly 
diagnosed vascular malformations with a prevalence of 
0.4-0.9%. Prospective autopsy series have confirmed 
the incidence of cavernous angiomas from 0.49 to 
0.53% [5]. Multiple lesions comprise 15-30% of all 
cases [6].
Familial cavernous angiomatosis represents an 
autosomal dominant disorder [7, 8] which is most 
common among Latino families. It comprises 10-15% 
of the total number of cavernoma cases [9]. In the 
familial form of cavernous angiomatosis, multiple 
lesions are present in 3/4 of patients.
Studies have shown changes on at least three different 
genes, affecting the occurrence of the familial form: 
CCM1 and CCM2 genes located on chromosome 7 and 
CCM3 gene located on chromosome 3, not yet 
completely analyzed [4, 10].
Objective
Literature review does not indicate that investigations 
of families with the familial cavernous angiomatosis 
have been carried out on the territory of Serbia. This is 
the first time that members of a family with multiple 
cavernous angiomatosis of the brain have been 
examined and the results analyzed and presented in a 
paper. MR imaging with T1 and T2 sequences and T2 
GRE (Gradient Recalled Echo) sequences was performed 
on all of the studied patients. The MR findings in 
symptomatic and asymptomatic patients, as well as the 
type and number of lesions, were compared, according 
to the classification by Zabramski [11]. The number of 
cavernous changes in various brain regions was 
analyzed.
Materials and Methods
In 2008, three patients in close blood relation were 
treated for intracranial hemorrhage at the Department 
of Neurosurgery, Niš. MR exploration of the intracranium 
was subsequently conducted on three other members 
of this family and the MR images made prevously for 
epileptic equivalents were reviewed with regard to one 
more person. MR imaging of the brain using T1 and T2 
SE sequences, as well as T2 GRE sequences, was 
performed on all the patients. The MRI equipment used 
was the Siemens Avanto 1.5T MRI Scanner.
All findings were independently reviewed by two 
specialists, radiologists and neurosurgeons. T1, T2 and 
T2 GRE sequences were compared and analysed with 
regard to the number and type of lesions found during 
the MR exploration.
Types and numbers of cavernous angioma were 
processed according to the classification by Zabrimski.
Statistical data were processed in the Statistica 8 soft 
(StatSoft, Tulsa) program, using the Mann-Whitney U 
test and Wilcoxon signed-Rank test.
Results
Type I lesions are characterized by subacute 
hemorrhage in the zone with the present change. On 
transverse sections, on T1 SE sequence, type I is 
characterized by the existence of a broad lesion 
involving a zone of high-signal intensity and a zone of 
low-signal intensity which indicates a more recent 
bleeding. T2 SE sequence shows the zone of bleeding 
more clearly. T2 GRE sequence clearly demarcates the 
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Figure 1. Type I cavernoma revealed in 
T1-weighted SE sequence.
Figure 2. Type I cavernoma revealed in 
T2-weighted SE sequence.
Figure 3. Type I cavernoma revealed in T2 
GRE sequence.
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Type II is a lesion with bleeding and thrombosis zones 
in multiple time intervals. It typically appears as most 
commonly verified, raspberry-like cavernoma of the 
brain. Type II lesion is shown in Figures 4, 5 and 6 with 
the central reticular nucleus and peripheral low-signal 
rim.
Figure 4. Type II cavernoma in T1-weighted sequence, with 
central reticular nucleus and a zone of peripheral low-signal 
intensity, resulting from the accummulated hemosiderin.
Figure 5. Type II cavernoma in T2-weighted 
sequence with a more clearly demarcated 
hemosiderin zone.
Figure 6. Type II cavernoma in T2 GRE sequence 
most clearly demarcating multiple Type II 
cavernomas as zones of low-signal intensity.
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Type III lesion is characterized by chronic hemorrhage 
with hemosiderin within the lesion itself. With type III 
angiomas, the lesion is best displayed on the transverse 
T2 sequence as a zone of homogeneous low-signal 
intensity, as well as on GRE sequences, as shown in 
Figures 7, 8, 9.
Figure 7. T1-weighted sequence not clearly 
displaying Type III lesion.
Figure 8. Clearly displayed uniform 
hyposignal Type III lesion on T2-weighted 
SE sequence.
Figure 9. Type III lesion most clearly 
displayed on T2 GRE sequence.
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Type IV is still an unclear type of lesion and may 
correspond to capillary telangiectasia or a cavernoma 
in an early stage of development. Type IV is characteristic 
of the familial form of cavernomatosis and is shown in 
Figures 10, 11 and 12.
The discrepancy between the SE and GRE findings of 
type IV cavernous angioma is a feature of the familial 
form of cavernous angiomatosis.
The obtained results in terms of the total number of 
cavernomas, number of lesions in asymptomatic and 
symptomatic patients, number of cavernomas found 
on T2 and GRE sequences and localization of cavernoma 
are presented in tables (Tables 1-5).
Figure 10. Type IV lesion not clearly 
displayed on T1-weighted sequence.
Figure 11. Type IV cavernoma not 
displayed on T2-weighted sequence.
Figure 12. Hyposignal zones of multiple Type IV 
cavernomas in the white matter of the brain clearly 
displayed on T2 GRE sequence.
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Table 1. Number of lesions in certain brain regions.
Region Number of lesions
Brainstem 4        (0.98%)
Cerebellum 23      (5.70%)
Occipital lobe 97      (23.90%)
Parietal lobe 102    (25.12%)
Temporal lobe 116    (28.60%)
Frontal lobe 64      (15.80%)
Table 2. Total number of cavernomas seen on MR GRE and MR T2 sequences.
GRE sequences T2 sequences
Type I 4     (0.98%) 4     (6.66%)
Type II 46   (11.33%) 46   (76.68%)
Type III 10   (2.46%) 10   (16.66%)
Type IV 346 (85.23%) *
*Type IV cavernomas may be detected on SE sequences
Table 3. Number and location of lesions detected on MR T2-weighted sequences, in symptomatic and asymptomatic patients.
Number of lesions Location of lesion
Total number Mean value* Supratentorially Infratentorially
Symptomatic patients 46 15.33 39 (84.8%) 7 (15.2%)
Asymptomatic 
patients 14  7  7 (50%) 7 (50%)
* Mean values represent calculated mean values of the number of lesions per patient
Table 4. Number and location of lesions detected on MR GRE sequences.
Number of lesions Location of lesion
Total number Mean value Supratentorially Infratentorially
Symptomatic patients 298 99.33 282 (94.6%) 16 (5.37%)
Asymptomatic 
patients 108 54 97 (89.8%) 11 (10.2%)
Numbers in brackets represent percentages
Table 5. Distribution of the cavernoma types on MR GRE sequence, in symptomatic and asymptomatic patients.


















patients 4 1.33 35 11.66 7 2.33 252 84
Asymptomatic 
patients 0 0 11 5.5 3 1.5 94 47
* Mean values represent calculated mean values of the number of lesions per patient
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Discussion
Cavernous angioma belongs to a group of hamartomas 
of the blood vessels [12]. It is an occult malformation 
that is not displayed on the classic angiography. 
Multiple familial cavernous angiomatosis is defined by 
the existence of two or more brain lesions in two or 
more family members or by the presence of a gene 
mutation causing the disease [13, 14].
With the development of MR imaging, cavernomas are 
becoming the most commonly diagnosed vascular 
malformation of the brain, with a prevalence of 0.4-
0.9%, as confirmed by autopsy findings. The familial 
form is present in 6-50% of all lesions, and is most 
often associated with the Latin American origin [15].
Clinical manifestation
Cavernous angiomas are most often clinically 
manifested as epileptic equivalents (38-55%), focal 
neurologic deficit (12-45%), non-specific headaches 
(5-55%) and intracranial hemorrhage (4-32%) [5]. 
Different studies speak about 10-90% of the 
symptomatic patients [16, 17]. Our findings suggest 
that 20% of the patients with the examined changes 
have epileptic seizures, 60% focal neurological deficits, 
60% headache and 60% hemorrhage. Literature data 
[16] indicate that most patients become symptomatic 
between the third and fifth decade of life, while the 
results of our study show a slightly higher mean age of 
the patients, 51 years.
Asymptomatic patients
In our study, 40% of the patients are asymptomatic. The 
true incidence of familial form of the disease is probably 
concealed by a large number of asymptomatic patients.
Presence of multiple lesions in treated patients
Multiple lesions are found in 50-84% of the patients 
with the familial form of the disease [5]. Multiple 
changes are observed in all of the subjects from our 
study, more than 40 lesions per patient. According to 
most authors, there is no significant correlation 
between the number of changes in the brain and 
presentation of the disease, as our investigation also 
showed.
Number of lesions infratentorially and supratentorially
Literature data [5] indicate that the lesions are often 
positioned supratentorially (80-85%), whereas in our 
study the number of supratentorial lesions makes 
76.66% of the total number seen on SE sequences, i. e. 
93.34% of the total number of lesions seen on GRE 
sequences.
Number of lesions in certain brain regions
Of the total number of cavernomas, the largest number, 
i. e. 28.57%, is positioned in the temporal lobe and 
25.12% in the parietal lobe, whereas the smallest 
number, i. e. 0.98%, is located in the brain stem (data 
from Table 1).
Number of lesions seen in T1, T2 and T2 GRE sequences
The total number of lesions seen on SE sequences in all 
treated patients is 60. The number of lesions seen on T2 
GRE sequences in all the patients is 406. T2 GRE 
exploration is clearly more sensitive, compared to T1 
and T2 sequences in presenting the cavernous 
angioma, which was statistically confirmed (data from 
Tables 2-5).
All our symptomatic patients have type I change, which 
is the cause of the neurological deficit or epileptic 
seizures. As there is no statistical significance in the 
total number of lesions in asymptomatic and 
symptomatic patients, the presence of type I lesions 
determines clinical presentation in our examined 
patients. According to the majority of available papers, 
the presence of type I and type II lesions determines 
the clinical picture (5.16).
The number of lesions increases with the patient's age. 
The oldest patient is 73 years old presenting with 187 
changes, which proportionately increases by number, 
type and size of cavernoma.
The total number of changes regardless of the type of 
cavernoma in symptomatic patients is 298, in 
comparison to 108 in asymptomatic patients.
The total number of changes regardless of the type of 
cavernoma registered by exploration in T2 sequences is 
60, and the number registered in GRE sequences is 406. 
After comparing the number of lesions found on T2 
and T2 GRE sequences in all the patients, a significant 
difference was obtained by using the Wilcoxon signed-
rank test (Z = 2.023, p = 0.043).
Type IV cavernoma was the most commonly found 
change, with a total number of 346.
By applying the Mann-Whitney U test, no significant 
difference was found in the medians of the number of 
lesions in SE sequences in asymptomatic and 
symptomatic patients (U = 0.5, p = 0.139, r = 0.062)
By applying the Mann-Whitney U test, no significant 
difference was found in the medians of the number of 
lesions in GRE sequences in symptomatic and 
asymptomatic patients (U = 2, p = 0.564, r = 0.2576). 
From the foregoing, it is concluded that the number of 
lesions does not have a major impact on the clinical 
presentation of the desease.
Changes relating to type I cavernoma were not found 
in asymptomatic patients. All three symptomatic 
patients had type I cavernoma which was the cause of 
the neurological deficits or epileptic seizures.
In the oldest of the symptomatic patients, 73 years of 
age, a total of 187 changes were registered. The 
youngest symptomatic patient had a total of 55 
changes. Type IV cavernoma is the most frequently 
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encountered type of cavernomas. Literature data [5] 
confirm that the number of lesions and their size grow 
throughout life.
Conclusion
This paper deals with six family members from the first 
to third degree of consanguinity. In five patients, MRI 
revealed the existence of multiple cavernous angiomas. 
MR imaging of the brain is the method of choice in 
proving this type of vascular malformations. The 
superiority of MR GRE (Gradient Recalled Echo) 
sequences was shown to be superior in the diagnosis 
of lesions of the familial cavernous angiomatosis of the 
brain, making such images obligatory during the MR 
exploration of cavernomas due to their apparently 
greater sensitivity.
In the case of familial form of cavernous angiomatosis, 
the existence of Type IV cavernomas (classification 
according to Zabramski) is characteristic of the disease. 
Type IV cavernomas are detectable only when GRE 
sequences are used, as they cannot be detected by the 
classic SE exploration.
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